✦ LIBER ✦

Busulfan versus cyclophosphamide treatment in the early and late stages of granulocytic leukemia in guinea pigs

✍ Scribed by Warren H. Evans; Denise A. Miller; John W. Pearson; Richard V. Smalley; Dorothy E. Moore; Howard K. Terebelo

Book ID: 113238284
Publisher: Elsevier Science
Year: 1984
Tongue: English
Weight: 435 KB
Volume: 8
Category: Article
ISSN: 0145-2126
DOI: 10.1016/0145-2126(84)90058-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of busulfan and cyclophospham

Comparison of busulfan and cyclophosphamide in the treatment of chronic myelocytic leukemia

✍ David T. Kaung; Henry P. Close; Richard M. Whittington; Mary Ellen Patno 📂 Article 📅 1971 🏛 John Wiley and Sons 🌐 English ⚖ 368 KB 👁 2 views

Porty-one patients with chronic myelocytic leukemia were treated with busulfan, 0.1 mg/kg/day, or cyclophosphamide, 2.0 mg/kg/day, orally for 8-12 weeks in a double-blind study. In the busulfan-treated group, there were 5 complete remissions, 10 partial remissions, 4 slight remissions, and no remiss

Content of lysosomal cationic proteins i

Content of lysosomal cationic proteins in neutrophilic granulocytes of rabbits and guinea pigs in the early stage of acute radiation sickness

✍ G. N. Sushkevich; A. N. Solodovnikova; A. G. Aladatov 📂 Article 📅 1980 🏛 Springer US 🌐 English ⚖ 157 KB

Treatment of chronic lymphocytic leukemi

Treatment of chronic lymphocytic leukemia in advanced stages. A randomized trial comparing chlorambucil plus prednisone versus cyclophosphamide, vincristine, and prednisone

✍ Emilio Montserrat; Antonio Alcalá; Ricardo Parody; Andreu Domingo; Javier García 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 685 KB

Ninety-six patients with advanced chronic lymphocytic leukemia (CLL) (Stage C; anemia and/or thrombocytopenia of nonimmune origin) were randomized to receive either chlorambucil (CLR) (0.4 mg/kg orally, day 6) plus prednime (PDN) (60 mg/m2 orally, days 1-5) every 2 weeks or cyclophosphamide (600 mg/

Changes in lymphocyte subsets after trea

Changes in lymphocyte subsets after treatment with cyclophosphamide and during the development of contact sensitivity in the guinea pig

✍ D.Baker Kerstin Karcher; A.V. Antoniou; J.L. Turk; B.T.G. Tan; R.J. Scheper 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 665 KB

Systematic Review of the Treatment of Ki

Systematic Review of the Treatment of Kienböck's Disease in Its Early and Late Stages

✍ Lindsay Innes; Robert J. Strauch 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 420 KB

Systematic Review of the Treatment of Ki

Systematic Review of the Treatment of Kienböck's Disease in Its Early and Late Stages

✍ Lindsay Innes; Robert J. Strauch 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 420 KB

Purpose To perform a systematic review of the treatment of Kienböck's disease to test the hypothesis that none of the reported treatments for Kienböck's disease is superior with respect to outcomes of pain, motion, grip strength, and radiographic measures. ## Methods We searched PubMed, Medline,